Trial Profile
A Randomized Open-label Study to Evaluate the Efficacy and Safety of Tacrolimus and Corticosteroids in Comparison With Mycophenolate Mofetil and Corticosteroids in Subjects With Class III/IV±V Lupus Nephritis
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2023
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Corticosteroids; Mycophenolate mofetil
- Indications Lupus nephritis
- Focus Therapeutic Use
- 11 Dec 2023 Planned End Date changed from 30 Jun 2024 to 31 Jan 2025.
- 11 Dec 2023 Planned primary completion date changed from 30 Jun 2024 to 31 Jan 2025.
- 11 Dec 2023 Status changed from recruiting to active, no longer recruiting.